Lb Pharmaceuticals (LBRX) Shares Outstanding (2024 - 2026)

Lb Pharmaceuticals has reported Shares Outstanding for 3 years, with the latest figure at $28.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 11294.5% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $28.7 million (up 11294.5% YoY), and the FY2025 full-year result was $25.3 million, up 9953.2% from the prior year.
• Shares Outstanding for Q1 2026 stood at $28.7 million, up from $25.3 million in the prior quarter.
• The five-year high for Shares Outstanding was $28.7 million in Q1 2026, with the low at $251655.0 in Q3 2024.
• Average Shares Outstanding over 3 years is $9.7 million, with a median of $1.7 million recorded in 2024.
• Year-over-year, Shares Outstanding surged 1168.14% in 2025 and soared 11294.5% in 2026.
• Tracing LBRX's Shares Outstanding over 3 years: stood at $251655.0 in 2024, then soared by 9953.2% to $25.3 million in 2025, then advanced by 13.34% to $28.7 million in 2026.
• The last three Shares Outstanding figures came in at $28.7 million (Q1 2026), $25.3 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.

Peer Comparison